These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38554673)

  • 1. Radiogenomic analysis based on lipid metabolism-related subset for non-invasive prediction for prognosis of renal clear cell carcinoma.
    He H; Xie Y; Song F; Feng Z; Rong P
    Eur J Radiol; 2024 Jun; 175():111433. PubMed ID: 38554673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative radiogenomics analysis for predicting molecular features and survival in clear cell renal cell carcinoma.
    Zeng H; Chen L; Wang M; Luo Y; Huang Y; Ma X
    Aging (Albany NY); 2021 Mar; 13(7):9960-9975. PubMed ID: 33795526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.
    Gao J; Ye F; Han F; Wang X; Jiang H; Zhang J
    Front Oncol; 2021; 11():739815. PubMed ID: 34692518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
    Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
    World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the ADAM12 Expression in Clear Cell Renal Cell Carcinoma: A Radiogenomic Analysis on CT Imaging.
    Greco F; Panunzio A; Bernetti C; Tafuri A; Beomonte Zobel B; Mallio CA
    Acad Radiol; 2024 Sep; 31(9):3672-3677. PubMed ID: 38485610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomics in renal cell carcinoma.
    Alessandrino F; Shinagare AB; Bossé D; Choueiri TK; Krajewski KM
    Abdom Radiol (NY); 2019 Jun; 44(6):1990-1998. PubMed ID: 29713740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study.
    Liu DH; Dani KA; Reddy SS; Lei X; Demirjian NL; Hwang DH; Varghese BA; Rhie SK; Yap FY; Quinn DI; Siddiqi I; Aron M; Vaishampayan U; Zahoor H; Cen SY; Gill IS; Duddalwar VA
    Oncology; 2023; 101(6):375-388. PubMed ID: 37080171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of CT radiomics for prediction of distant metastasis after surgical resection in patients with clear cell renal cell carcinoma: exploring the underlying signaling pathways.
    Zhao Y; Liu G; Sun Q; Zhai G; Wu G; Li ZC
    Eur Radiol; 2021 Jul; 31(7):5032-5040. PubMed ID: 33439312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.
    Tang F; Zhang J; Zhu L; Lai Y; Li Z; Lu Z; Tang Z; Mai Y; Huang R; He Z
    Urol J; 2022 May; 19(4):289-299. PubMed ID: 35598038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients.
    Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B
    Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Computed Tomography-Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer.
    Liu H; Wang Y; Liu Y; Lin D; Zhang C; Zhao Y; Chen L; Li Y; Yuan J; Chen Z; Yu J; Kong W; Chen T
    Front Oncol; 2022; 12():882786. PubMed ID: 35814414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.